Shares of GSK PLC GSK inched up 0.59% to £13.64 Thursday, on what proved to be an all-around positive trading session for the ...
Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...
Arcos Dorados Holdings Inc. ARCO is a franchisee of McDonald’s restaurants. The Zacks Consensus Estimate for its current year ...
BV100 is a new formulation of rifabutin suitable for intravenous administration that BioVersys claims offers a new mechanism ...
The "Ovarian Cancer Market by Type, by Diagnosis Scans, by Treatment, by End-user, and by Region" report has been added to ...
Tata AIG has appointed Shekhar Saurabh as its Head of Marketing. The news has been shared by Saurabh in a LinkedIn update.
DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today! LONDON, GREATER LONDON , UNITED KINGDOM, January 23, 2025 /EINPresswire / -- What's ...
Investor's Business Daily on MSN9h
Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?In the meantime, its Covid vaccine has yet to hit a bottom and its RSV vaccine is coming from behind in competition with ...
There were also strong gains for GSK's majority-owned HIV business ViiV Healthcare, up 19% to £1.5 billion, and anti-inflammatory medicines Nucala (mepolizumab) and Benlysta (belimumab).
Malaria kills more than a thousand children every day. Measures like antimalarial medications and insecticide-treated bed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback